Safwaan Adam | Dr Safwaan Adam - Chief Medical and Safety Officer (Fractional)
OpalMedica

Dr Safwaan Adam is Chief Medical and Safety Officer (Fractional) at OpalMedica, providing strategic medical and safety leadership to support the development of innovative products. He combines a strong clinical background and academic record with expertise in clinical and medical strategy, patient safety, benefit–risk assessment and governance throughout the product development lifecycle. His approach brings clinical insight and scientific rigour to the challenges facing biotech and pharmaceutical organisations, particularly in complex and underserved disease areas, with patient needs and meaningful outcomes central to decision-making. At World Orphan Drug Congress 2026, Dr Adam will contribute to discussions on strategy, advocacy and partnering to advance therapies for people living with rare diseases.